Propel Bio Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-34,494	Closed	-$500K	–	23
2024 Q3	$500K	Sell	34,494 -8,000	-19%	-$116K	0.29%	19
2024 Q2	$3.1M	Buy	+42,494	New	+$3.1M	2.01%	14